Serious riskFDA DrugClass I

Baxter Dextrose Injection 70% recalled for stainless steel particles

Baxter Healthcare identified stainless steel particles in certain 2000 mL bags of Dextrose Injection, USP 70%. The contamination affected 606 bags (Lot #Y495066, expiration July 31, 2027) distributed nationwide. No injuries have been reported.

From the FDA notice · Read the official notice ↗ · All Baxter recalls

What to do

  1. Do not use affected bags of Dextrose Injection, USP 70%, Lot #Y495066.
  2. Contact Baxter Healthcare or your pharmacy for guidance on safe disposal and replacement.
  3. Check your facility's inventory for the recalled lot number.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL, 60016, Made in USA, NDC 00338-0719-06
Sold in
Nationwide
Made for
All ages (0 months and older)

Details

Units affected
606 bags
Illnesses reported
None reported
Manufactured in
1 Baxter Pkwy, Deerfield, IL, United States
Classification
Class I
Recall number
D-0850-2026

In the FDA's words

Description
Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL, 60016, Made in USA, NDC 00338-0719-06 Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution. Lot #: Y495066, Exp. Date July 31, 2027 Distribution: U.S. Nationwide. Affected quantity: 606 bags
Hazard
Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.

More from Baxter

See all

Related topics

ParticulateDrugsSold nationwideMore from FDA Drug